Daniel J. MacPhee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel J. MacPhee has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Ewa I. Miskiewicz
Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada (Miskiewicz and MacPhee)
7 shared publications- John C. S. Harding
Department of Large Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada
6 shared publications - Jonathan Alexander Pasternak
Department of Animal and Food Sciences, University of Kentucky, Lexington, USA
5 shared publications E. I. Miskiewicz
Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada
4 shared publications- Glenn Hamonic
Department of Large Animal Clinical Sciences, University of Saskatchewan, Saskatoon, Canada
3 shared publications - Muhammad Suleman
Department of Pathology, University of Veterinary and Animal Sciences, Lahore, Pakistan
3 shared publications
Latest Publications
- Open Access
Multilayer and Biomimetic Polycaprolactone/Uterine ECM Scaffold for Uterine Tissue Engineering and Anti-Adhesion Barrier Applications via 3D-Printing Near-Field Melt Electrowriting
Background: Post-operative uterine adhesions remain a major clinical challenge, often leading to infertility and severe pelvic pain. Current anti-adhesion barriers lack the mechanical strength, tissue specificity, or bioactivity required for optimal regeneration of uterine tissue. To address these limitations, we developed a biomimetic, multilayer scaffold that replicates the structural and functional complexity of the myometrial and serosal layers of the uterus by combining a tunable polycaprolactone (PCL) mesh with a bioactive hydrogel derived from decellularized uterine extracellular matrix (dUECM) reinforced with sodium alginate (Alg). Materials and Methods: Composite scaffolds were fabricated using near-field melt electrowriting (MEW) to create precision-engineered PCL meshes with various infill angles (90°, 60°, 45°, and 30°), followed by impregnation with an alginate-dUECM hydrogel. A comprehensive physicochemical characterization was conducted using Fourier Transform Infrared Spectroscopy (FTIR), Thermogravimetric Analysis (TGA), and contact angle measurements. Mechanical properties were evaluated in both dry and wet states via uniaxial tensile testing. Swelling and degradation were assessed over 10 days. hTERT-HM cells were used for in vitro evaluation through Live/Dead staining, MTT, SEM, and immunocytochemistry for α-SMA and DAPI. Results: The successful incorporation of the hydrogel into the PCL mesh was confirmed by the results obtained from FTIR and TGA analyses; these findings were further supported by contact angle studies, which showed a marked increase in hydrophilicity, resulting in a reduction of the static contact angle from 113 ± 4° in the pure PCL to 60 ± 12° in the hydrogel-infiltrated samples in the 30° group. Mechanical testing showed that the wet composite scaffolds maintained higher stiffness than hydrated native uterine tissue. Cell culture assays confirmed excellent cytocompatibility and proliferation, especially in 30α infill architecture. Immunofluorescence revealed strong α-SMA expression and cytoskeletal organization, indicating phenotypic maturation of uterine smooth muscle cells for all groups. Conclusion: Among all groups, the 30α MEW mesh impregnated with Alg-dUECM hydrogel demonstrated the most balanced combination of mechanical resilience, degradation profile, wettability, and cellular compatibility. This structure most closely recapitulates the biological characteristics of uterine outer myometrium tissue, positioning it as a highly promising scaffold for regeneration and biofunctional anti-adhesion barrier applications.
Open AccessMultilayer and Biomimetic Polycaprolactone/Uterine ECM Scaffold for Uterine Tissue Engineering and Anti-Adhesion Barrier Applications via 3D-Printing Near-Field Melt Electrowriting
Background: Post-operative uterine adhesions remain a major clinical challenge, often leading to infertility and severe pelvic pain. Current anti-adhesion barriers lack the mechanical strength, tissue specificity, or bioactivity required for optimal regeneration of uterine tissue. To address these limitations, we developed a biomimetic, multilayer scaffold that replicates the structural and functional complexity of the myometrial and serosal layers of the uterus by combining a tunable polycaprolactone (PCL) mesh with a bioactive hydrogel derived from decellularized uterine extracellular matrix (dUECM) reinforced with sodium alginate (Alg). Materials and Methods: Composite scaffolds were fabricated using near-field melt electrowriting (MEW) to create precision-engineered PCL meshes with various infill angles (90°, 60°, 45°, and 30°), followed by impregnation with an alginate-dUECM hydrogel. A comprehensive physicochemical characterization was conducted using Fourier Transform Infrared Spectroscopy (FTIR), Thermogravimetric Analysis (TGA), and contact angle measurements. Mechanical properties were evaluated in both dry and wet states via uniaxial tensile testing. Swelling and degradation were assessed over 10 days. hTERT-HM cells were used for in vitro evaluation through Live/Dead staining, MTT, SEM, and immunocytochemistry for α-SMA and DAPI. Results: The successful incorporation of the hydrogel into the PCL mesh was confirmed by the results obtained from FTIR and TGA analyses; these findings were further supported by contact angle studies, which showed a marked increase in hydrophilicity, resulting in a reduction of the static contact angle from 113 ± 4° in the pure PCL to 60 ± 12° in the hydrogel-infiltrated samples in the 30° group. Mechanical testing showed that the wet composite scaffolds maintained higher stiffness than hydrated native uterine tissue. Cell culture assays confirmed excellent cytocompatibility and proliferation, especially in 30α infill architecture. Immunofluorescence revealed strong α-SMA expression and cytoskeletal organization, indicating phenotypic maturation of uterine smooth muscle cells for all groups. Conclusion: Among all groups, the 30α MEW mesh impregnated with Alg-dUECM hydrogel demonstrated the most balanced combination of mechanical resilience, degradation profile, wettability, and cellular compatibility. This structure most closely recapitulates the biological characteristics of uterine outer myometrium tissue, positioning it as a highly promising scaffold for regeneration and biofunctional anti-adhesion barrier applications.
- Open Access
- 24 June 2025
- Published by MDPI AG in Preprints.org
Development and Evaluation of an Alginate-Decellularized Uterine Extracellular Matrix Hydrogel for 3D Bioprinting of Uterine Constructs
Background and aim: Decellularized uterine extracellular matrix (dUECM) holds promise for uterine tissue engineering due to its preserved bioactive components and structural integrity. However, bioprinting uterine constructs from dUECM remains unachievable due to the dUECM properties limited for bioprinting. To address issues, this study aimed to (1) develop a one-step protocol to effectively decellularize uterine and (2) synthese dUECM with alginate to form a novel bioactive hydrogel for bioprinting uterine constructs. The in vitro characterization of Alg:dUECM hydrogels with seeded human uterine myometrial-human telomerase reverse transcriptase cells (hTERT-HM) cells has been pursued in terms of mechanical stability, printability and bioactivity for uterine tissue engineering. Materials and Methods: Uterine tissues were decellularized using a one-step protocol with 1% Triton™ X-100 and varying sodium dodecyl sulfate (SDS) concentrations (0.1% - 1.5%) for 48 and 72 hours. Decellularized tissues were analyzed in different forms: fresh samples for tensile testing and histology (DAPI, H&E, Masson's trichrome), freeze-dried samples for SEM imaging, and powdered samples for DNA quantification, glycosaminoglycan (GAG) content, FT-IR, Raman spectroscopy, and TGA. Selected dUECM samples were digested with pepsin and acetic acid, and their rheology and gelation behaviour were assessed. Hydrogels were prepared by combining 2% and 3% alginate with 0.5%, 1%, and 1.5% dUECM. The resulting hydrogels were evaluated for swelling, degradation, mechanical properties, and printability. Biocompatibility was assessed using MTT and Live/Dead assays with hTERT-HM cells seeded on the selected hydrogel. Main Results: The decellularization protocol (1% Triton™ X-100 + 1% SDS for 48 hours) effectively reduced DNA content to 51.33 ± 9.02 ng/mg, nearing the immunogenic threshold of 50 ng/mg, with no visible nuclei, confirming efficient removal of cellular material. Additionally, GAG retention remained high at 54.94 ± 7.55 µg/mg dry weight after 48 hours, comparable to native tissue. FT-IR and Raman spectroscopy analyses confirmed the preservation of collagen's triple-helical structure (Amide III/1450: 1.04 ± 0.03, 1660/1620: 1.32 ± 0.11) with a reduction in thermal stability (TGA peak shift to ≈312°C, peak area 67.18 ± 4.59, p<0.001). In 3D printing studies, 3% Alg + 1.5% dUECM demonstrated the best structural properties, with a balanced printability factor (1.56 ± 0.20), enhanced swelling stability (47 ± 12% at day 14), and superior degradation resistance (94 ± 18% mass retention at day 14). Mechanical analysis confirmed strong structural integrity, with Young’s modulus decreasing from 322.7 ± 50.9 kPa at day 0 to 174.8 ± 29.8 kPa at day 14, outperforming other compositions. Cell viability assays demonstrated that 3% Alg + 1.5% dUECM exhibited a significant hTERT-HM proliferation (258.14 ± 12.83% by day 7, p = 0.0003) compared to 3% Alginate, with enhanced cell attachment. Conclusions: This study demonstrates that the protocol with 1% Triton™ X-100 + 1% SDS can remove cells while preserving ECM components effectively. A hydrogel synthesized from 3% Alg + 1.5% dUECM has appropriate printability, mechanical stability, and able to support cell attachment and proliferation. Collectively, these findings pave the road to engineering uterine tissue for medical applications.
- 24 June 2025
- Published by MDPI AG in Preprints.org
Open AccessDevelopment and Evaluation of an Alginate-Decellularized Uterine Extracellular Matrix Hydrogel for 3D Bioprinting of Uterine Constructs
Background and aim: Decellularized uterine extracellular matrix (dUECM) holds promise for uterine tissue engineering due to its preserved bioactive components and structural integrity. However, bioprinting uterine constructs from dUECM remains unachievable due to the dUECM properties limited for bioprinting. To address issues, this study aimed to (1) develop a one-step protocol to effectively decellularize uterine and (2) synthese dUECM with alginate to form a novel bioactive hydrogel for bioprinting uterine constructs. The in vitro characterization of Alg:dUECM hydrogels with seeded human uterine myometrial-human telomerase reverse transcriptase cells (hTERT-HM) cells has been pursued in terms of mechanical stability, printability and bioactivity for uterine tissue engineering. Materials and Methods: Uterine tissues were decellularized using a one-step protocol with 1% Triton™ X-100 and varying sodium dodecyl sulfate (SDS) concentrations (0.1% - 1.5%) for 48 and 72 hours. Decellularized tissues were analyzed in different forms: fresh samples for tensile testing and histology (DAPI, H&E, Masson's trichrome), freeze-dried samples for SEM imaging, and powdered samples for DNA quantification, glycosaminoglycan (GAG) content, FT-IR, Raman spectroscopy, and TGA. Selected dUECM samples were digested with pepsin and acetic acid, and their rheology and gelation behaviour were assessed. Hydrogels were prepared by combining 2% and 3% alginate with 0.5%, 1%, and 1.5% dUECM. The resulting hydrogels were evaluated for swelling, degradation, mechanical properties, and printability. Biocompatibility was assessed using MTT and Live/Dead assays with hTERT-HM cells seeded on the selected hydrogel. Main Results: The decellularization protocol (1% Triton™ X-100 + 1% SDS for 48 hours) effectively reduced DNA content to 51.33 ± 9.02 ng/mg, nearing the immunogenic threshold of 50 ng/mg, with no visible nuclei, confirming efficient removal of cellular material. Additionally, GAG retention remained high at 54.94 ± 7.55 µg/mg dry weight after 48 hours, comparable to native tissue. FT-IR and Raman spectroscopy analyses confirmed the preservation of collagen's triple-helical structure (Amide III/1450: 1.04 ± 0.03, 1660/1620: 1.32 ± 0.11) with a reduction in thermal stability (TGA peak shift to ≈312°C, peak area 67.18 ± 4.59, p<0.001). In 3D printing studies, 3% Alg + 1.5% dUECM demonstrated the best structural properties, with a balanced printability factor (1.56 ± 0.20), enhanced swelling stability (47 ± 12% at day 14), and superior degradation resistance (94 ± 18% mass retention at day 14). Mechanical analysis confirmed strong structural integrity, with Young’s modulus decreasing from 322.7 ± 50.9 kPa at day 0 to 174.8 ± 29.8 kPa at day 14, outperforming other compositions. Cell viability assays demonstrated that 3% Alg + 1.5% dUECM exhibited a significant hTERT-HM proliferation (258.14 ± 12.83% by day 7, p = 0.0003) compared to 3% Alginate, with enhanced cell attachment. Conclusions: This study demonstrates that the protocol with 1% Triton™ X-100 + 1% SDS can remove cells while preserving ECM components effectively. A hydrogel synthesized from 3% Alg + 1.5% dUECM has appropriate printability, mechanical stability, and able to support cell attachment and proliferation. Collectively, these findings pave the road to engineering uterine tissue for medical applications.
- Open Access
- 4 June 2025
- Published by Elsevier in AJOG Global Reports
- Vol. 5 (3) , 100533
Prospective determination of heat shock protein serum levels in Saskatchewan women during pregnancy
- 4 June 2025
- Published by Elsevier in AJOG Global Reports
- Vol. 5 (3) , 100533
Open AccessProspective determination of heat shock protein serum levels in Saskatchewan women during pregnancy
- Open Access
- 19 October 2022
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 159 (2) , 149-162
Phosphoserine-86-HSPB1 (pS86-HSPB1) is cytoplasmic and highly induced in rat myometrium at labour
Uterine myocytes during pregnancy proceed through a series of adaptations and collectively transform into a powerfully contractile tissue by term. Previous work has indicated that members of the heat shock protein (HSP) B family of stress proteins are associated with the process of adaptation and transformation. Utilizing immunoblot analyses, widefield epifluorescence and total internal reflection (TIRF) microscopy, this study investigated the temporal and spatial detection of HSPB1 phosphorylated on serine-86 (pS86-HSPB1) in rat myometrium during pregnancy, the role of uterine distension in regulation of pS86-HSPB1, and the comparative localization with pS15-HSPB1 in rat myometrial tissue as well as in an immortalized human myometrial cell line. Immunoblot detection of pS86-HSPB1 was significantly elevated during late pregnancy and labour. In particular, pS86-HSPB1 was significantly increased at day (d)22 and d23 (labour) compared with all other timepoints assessed. Localization of pS86-HSPB1 in myometrium became prominent at d22 and d23 with cytoplasmic detection around myometrial cell nuclei. Furthermore, pS86-HSPB1 detection was found to be significantly elevated in the gravid rat uterine myometrium compared with the non-gravid tissue at d19 and d23. Both widefield epifluorescence and TIRF microscopy examination of human myometrial cells demonstrated that pS15-HSPB1 was prominently localized to focal adhesions, while pS82-HSPB1 (homologous to rodent pS86-HSPB1) was primarily located in the cell cytoplasm. Our data demonstrate that levels of phosphorylated HSPB1 increase just prior to and during labour, and that uterine distension is a stress-inducing signal for HSPB1 phosphorylation. The exact roles of these phosphorylated forms in myometrial cells remain to be determined.
- 19 October 2022
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 159 (2) , 149-162
Open AccessPhosphoserine-86-HSPB1 (pS86-HSPB1) is cytoplasmic and highly induced in rat myometrium at labour
Uterine myocytes during pregnancy proceed through a series of adaptations and collectively transform into a powerfully contractile tissue by term. Previous work has indicated that members of the heat shock protein (HSP) B family of stress proteins are associated with the process of adaptation and transformation. Utilizing immunoblot analyses, widefield epifluorescence and total internal reflection (TIRF) microscopy, this study investigated the temporal and spatial detection of HSPB1 phosphorylated on serine-86 (pS86-HSPB1) in rat myometrium during pregnancy, the role of uterine distension in regulation of pS86-HSPB1, and the comparative localization with pS15-HSPB1 in rat myometrial tissue as well as in an immortalized human myometrial cell line. Immunoblot detection of pS86-HSPB1 was significantly elevated during late pregnancy and labour. In particular, pS86-HSPB1 was significantly increased at day (d)22 and d23 (labour) compared with all other timepoints assessed. Localization of pS86-HSPB1 in myometrium became prominent at d22 and d23 with cytoplasmic detection around myometrial cell nuclei. Furthermore, pS86-HSPB1 detection was found to be significantly elevated in the gravid rat uterine myometrium compared with the non-gravid tissue at d19 and d23. Both widefield epifluorescence and TIRF microscopy examination of human myometrial cells demonstrated that pS15-HSPB1 was prominently localized to focal adhesions, while pS82-HSPB1 (homologous to rodent pS86-HSPB1) was primarily located in the cell cytoplasm. Our data demonstrate that levels of phosphorylated HSPB1 increase just prior to and during labour, and that uterine distension is a stress-inducing signal for HSPB1 phosphorylation. The exact roles of these phosphorylated forms in myometrial cells remain to be determined.
- 28 June 2022
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 250, 110457
Detection of PRRSV-2 alone and co-localized with CD163 positive macrophages in porcine placental areolae
- 28 June 2022
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 250, 110457
Detection of PRRSV-2 alone and co-localized with CD163 positive macrophages in porcine placental areolae
- 14 March 2022
- Published by Elsevier in Theriogenology
- Vol. 184, 162-170
Effect of porcine reproductive and respiratory syndrome virus 2 on tight junction gene expression at the maternal-fetal interface
- 14 March 2022
- Published by Elsevier in Theriogenology
- Vol. 184, 162-170
Effect of porcine reproductive and respiratory syndrome virus 2 on tight junction gene expression at the maternal-fetal interface
- 3 November 2021
- Published by Oxford University Press (OUP) in Journal of Animal Science
- Vol. 99 (11)
Thyroid hormone suppression in feeder pigs following polymicrobial or porcine reproductive and respiratory syndrome virus-2 challenge
Thyroid hormones are powerful regulators of growth, development, and basal metabolic rate and can be dysregulated under conditions of severe stress or illness. To understand the role of these hormones in porcine disease response, serum samples were obtained from three batches of nursery-aged pigs (n = 208) exposed to a natural polymicrobial disease challenge with an array of bacterial and viral pathogens. Levels of total thyroxin (T4) and triiodothyronine (T3) assessed in sera by radioimmunoassay, decreased significantly by 14 days post-exposure (DPE). Levels of T3 partially rebounded by 48 DPE, while T4 levels remain depressed. Post-exposure T3 and T4 levels were positively correlated with acute and long-term average daily gain (ADG). Cross-sectional sampling of animals maintained at the high health source farms, showed no equivalent change in either hormone when managed under standard industrial conditions. To further elucidate the effect of porcine reproductive and respiratory syndrome virus (PRRSV)-infection on thyroid hormone levels, archived sera over 42 days post inoculation (DPI) from nursery pigs (N = 190) challenged with one of two PRRSV2 strains by the PRRS Host Genetics Consortium were similarly assessed, with animals selected in a two-by-two design, to investigate biological extremes in ADG and viral load (VL). All animals showed a similar decrease in both thyroid hormones reaching a minimum at 7 DPI and returning to near pre-challenge levels by 42 DPI. Post-challenge T3 and T4 levels were significantly greater in high ADG groups, with no significant association with VL or strain. The results of this study demonstrate porcine susceptibility to thyroid disruption in response to disease challenge and demonstrate a relationship between this response and growth performance.
- 3 November 2021
- Published by Oxford University Press (OUP) in Journal of Animal Science
- Vol. 99 (11)
Thyroid hormone suppression in feeder pigs following polymicrobial or porcine reproductive and respiratory syndrome virus-2 challenge
Thyroid hormones are powerful regulators of growth, development, and basal metabolic rate and can be dysregulated under conditions of severe stress or illness. To understand the role of these hormones in porcine disease response, serum samples were obtained from three batches of nursery-aged pigs (n = 208) exposed to a natural polymicrobial disease challenge with an array of bacterial and viral pathogens. Levels of total thyroxin (T4) and triiodothyronine (T3) assessed in sera by radioimmunoassay, decreased significantly by 14 days post-exposure (DPE). Levels of T3 partially rebounded by 48 DPE, while T4 levels remain depressed. Post-exposure T3 and T4 levels were positively correlated with acute and long-term average daily gain (ADG). Cross-sectional sampling of animals maintained at the high health source farms, showed no equivalent change in either hormone when managed under standard industrial conditions. To further elucidate the effect of porcine reproductive and respiratory syndrome virus (PRRSV)-infection on thyroid hormone levels, archived sera over 42 days post inoculation (DPI) from nursery pigs (N = 190) challenged with one of two PRRSV2 strains by the PRRS Host Genetics Consortium were similarly assessed, with animals selected in a two-by-two design, to investigate biological extremes in ADG and viral load (VL). All animals showed a similar decrease in both thyroid hormones reaching a minimum at 7 DPI and returning to near pre-challenge levels by 42 DPI. Post-challenge T3 and T4 levels were significantly greater in high ADG groups, with no significant association with VL or strain. The results of this study demonstrate porcine susceptibility to thyroid disruption in response to disease challenge and demonstrate a relationship between this response and growth performance.
- Open Access
Macroscopic, Histologic, and Immunomodulatory Response of Limb Wounds Following Intravenous Allogeneic Cord Blood-Derived Multipotent Mesenchymal Stromal Cell Therapy in Horses
Limb wounds are common in horses and often develop complications. Intravenous multipotent mesenchymal stromal cell (MSC) therapy is promising but has risks associated with intravenous administration and unknown potential to improve cutaneous wound healing. The objectives were to determine the clinical safety of administering large numbers of allogeneic cord blood-derived MSCs intravenously, and if therapy causes clinically adverse reactions, accelerates wound closure, improves histologic healing, and alters mRNA expression of common wound cytokines. Wounds were created on the metacarpus of 12 horses. Treatment horses were administered 1.51–2.46 × 108 cells suspended in 50% HypoThermosol FRS, and control horses were administered 50% HypoThermosol FRS alone. Epithelialization, contraction, and wound closure rates were determined using planimetric analysis. Wounds were biopsied and evaluated for histologic healing characteristics and cytokine mRNA expression. Days until wound closure was also determined. The results indicate that 3/6 of treatment horses and 1/6 of control horses experienced minor transient reactions. Treatment did not accelerate wound closure or improve histologic healing. Treatment decreased wound size and decreased all measured cytokines except transforming growth factor-β3. MSC intravenous therapy has the potential to decrease limb wound size; however, further work is needed to understand the clinical relevance of adverse reactions.
Open AccessMacroscopic, Histologic, and Immunomodulatory Response of Limb Wounds Following Intravenous Allogeneic Cord Blood-Derived Multipotent Mesenchymal Stromal Cell Therapy in Horses
Limb wounds are common in horses and often develop complications. Intravenous multipotent mesenchymal stromal cell (MSC) therapy is promising but has risks associated with intravenous administration and unknown potential to improve cutaneous wound healing. The objectives were to determine the clinical safety of administering large numbers of allogeneic cord blood-derived MSCs intravenously, and if therapy causes clinically adverse reactions, accelerates wound closure, improves histologic healing, and alters mRNA expression of common wound cytokines. Wounds were created on the metacarpus of 12 horses. Treatment horses were administered 1.51–2.46 × 108 cells suspended in 50% HypoThermosol FRS, and control horses were administered 50% HypoThermosol FRS alone. Epithelialization, contraction, and wound closure rates were determined using planimetric analysis. Wounds were biopsied and evaluated for histologic healing characteristics and cytokine mRNA expression. Days until wound closure was also determined. The results indicate that 3/6 of treatment horses and 1/6 of control horses experienced minor transient reactions. Treatment did not accelerate wound closure or improve histologic healing. Treatment decreased wound size and decreased all measured cytokines except transforming growth factor-β3. MSC intravenous therapy has the potential to decrease limb wound size; however, further work is needed to understand the clinical relevance of adverse reactions.
- 8 March 2021
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 155 (6) , 669-681
Examination of FERMT1 expression in placental chorionic villi and its role in HTR8-SVneo cell invasion
Transmembrane integrin receptors mediate cell–extracellular matrix as well as cell–cell adhesion. As placental trophoblast cells undergo differentiation they display changes in integrin expression or switching, but the mechanism(s) of integrin activation that supports this differentiation is still unknown. The Fermitin family of adapter proteins (FERMT 1–3) are integrin activators that mediate integrin-mediated signaling. In this study, we examined the spatiotemporal pattern of expression of FERMT1 in human chorionic villi throughout gestation and its role in HTR8-SVneo substrate adhesion and invasion. Placental villous tissue was obtained from patients undergoing elective terminations at weeks 8–14, as well as from term deliveries at weeks 37–40 and analyzed by immunofluorescence. Additionally, HTR8-SVneo trophoblast cells were transfected with FERMT1-specific siRNA or non-targeting siRNA (control) and used in cell-substrate adhesion as well as invasion assays. FERMT1 was primarily localized to membrane-associated regions at the base or around the periphery of the villous cytotrophoblast and proximal as well as distal cell column trophoblast. FERMT1 was also localized to endothelial cells of blood vessels in chorionic villi. siRNA-mediated depletion of FERMT1 in HTR8-SVneo cells did not markedly alter HTR8-SVneo cell-substrate adhesion but did significantly decrease invasion (P < 0.05) compared to control cells. These novel findings identify the presence of the integrin activator FERMT1 in trophoblast cells and that FERMT1 can regulate HTR8-SVneo cell invasion. FERMT1 may directly influence integrin activation and the subsequent integrin-mediated signaling and differentiation that underlies the acquisition of the invasive trophoblast phenotype in vivo.
- 8 March 2021
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 155 (6) , 669-681
Examination of FERMT1 expression in placental chorionic villi and its role in HTR8-SVneo cell invasion
Transmembrane integrin receptors mediate cell–extracellular matrix as well as cell–cell adhesion. As placental trophoblast cells undergo differentiation they display changes in integrin expression or switching, but the mechanism(s) of integrin activation that supports this differentiation is still unknown. The Fermitin family of adapter proteins (FERMT 1–3) are integrin activators that mediate integrin-mediated signaling. In this study, we examined the spatiotemporal pattern of expression of FERMT1 in human chorionic villi throughout gestation and its role in HTR8-SVneo substrate adhesion and invasion. Placental villous tissue was obtained from patients undergoing elective terminations at weeks 8–14, as well as from term deliveries at weeks 37–40 and analyzed by immunofluorescence. Additionally, HTR8-SVneo trophoblast cells were transfected with FERMT1-specific siRNA or non-targeting siRNA (control) and used in cell-substrate adhesion as well as invasion assays. FERMT1 was primarily localized to membrane-associated regions at the base or around the periphery of the villous cytotrophoblast and proximal as well as distal cell column trophoblast. FERMT1 was also localized to endothelial cells of blood vessels in chorionic villi. siRNA-mediated depletion of FERMT1 in HTR8-SVneo cells did not markedly alter HTR8-SVneo cell-substrate adhesion but did significantly decrease invasion (P < 0.05) compared to control cells. These novel findings identify the presence of the integrin activator FERMT1 in trophoblast cells and that FERMT1 can regulate HTR8-SVneo cell invasion. FERMT1 may directly influence integrin activation and the subsequent integrin-mediated signaling and differentiation that underlies the acquisition of the invasive trophoblast phenotype in vivo.